Select Medical Enters Definitive Agreement for $16.50/Share Take-Private Merger by Consortium

summarizeSummary

Select Medical Holdings Corporation has entered into a definitive merger agreement to be acquired by a consortium led by its Executive Chairman for $16.50 per share in cash, taking the company private.

check_boxKey Events

• Definitive Merger Agreement Signed

  Select Medical entered into a definitive agreement on March 2, 2026, to be acquired by a consortium led by its Executive Chairman, Robert A. Ortenzio, Martin F. Jackson, and Welsh, Carson, Anderson & Stowe (WCAS).

• Take-Private Transaction at $16.50 Per Share

  The company will be taken private, with unaffiliated shareholders receiving $16.50 per share in cash. This represents an enterprise value of $3.9 billion.

• Significant Premium to Unaffected Share Price

  The offer price of $16.50 per share represents an approximately 18% premium over Select Medical's unaffected share price as of November 24, 2025.

• Unanimous Board and Special Committee Approval

  The merger agreement was unanimously approved by the disinterested members of the Board of Directors upon the recommendation of a Special Committee of independent directors.

auto_awesomeAnalysis

This DEFA14A filing provides the full details of the definitive merger agreement, following previous disclosures of a non-binding offer and a preliminary proxy statement. The transaction, valued at $3.9 billion, offers a significant premium to the company's unaffected share price and has been unanimously approved by the Special Committee and disinterested board members. The deal is not subject to a financing condition, reducing execution risk, but requires approval from unaffiliated shareholders and regulatory bodies. This marks a critical step towards the company's privatization, fundamentally altering its investment thesis for public shareholders.